Carcinoid syndrome historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Carcinoid syndrome was first described by Siegfried Oberndorfer, a German [[pathologist]] in 1907. Endocrine related properties of carcinoids was described by Gosset and Masson in 1914. | Carcinoid syndrome was first described by Siegfried Oberndorfer, a German [[pathologist]] in 1907. Endocrine related properties of carcinoids was described by Gosset and Masson in 1914. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Carcinoids were first described in 1907 by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich, who coined the term ''karzinoide'', or "carcinoma-like", to describe the unique feature of behaving like a [[benign tumor]] despite having a [[malignant]] appearance microscopically. The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumors are now known to arise from the [[enterochromaffin]] (EC) and enterochromaffin-like (ECL) cells of the gut. | Carcinoids were first described in 1907 by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich, who coined the term ''karzinoide'', or "carcinoma-like", to describe the unique feature of behaving like a [[benign tumor]] despite having a [[malignant]] appearance microscopically.<ref name="pmid3959292">{{cite journal| author=Swiryn S, Hueter DC| title=The electrocardiogram in esophageal impaction. | journal=JAMA | year= 1986 | volume= 255 | issue= 15 | pages= 2067-8 | pmid=3959292 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3959292 }} </ref> The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumors are now known to arise from the [[enterochromaffin]] (EC) and enterochromaffin-like (ECL) cells of the gut. | ||
==References== | ==References== | ||
Revision as of 13:14, 29 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome historical perspective |
|
Risk calculators and risk factors for Carcinoid syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Carcinoid syndrome was first described by Siegfried Oberndorfer, a German pathologist in 1907. Endocrine related properties of carcinoids was described by Gosset and Masson in 1914.
Historical Perspective
Carcinoids were first described in 1907 by Siegfried Oberndorfer, a German pathologist at the University of Munich, who coined the term karzinoide, or "carcinoma-like", to describe the unique feature of behaving like a benign tumor despite having a malignant appearance microscopically.[1] The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumors are now known to arise from the enterochromaffin (EC) and enterochromaffin-like (ECL) cells of the gut.
References
- ↑ Swiryn S, Hueter DC (1986). "The electrocardiogram in esophageal impaction". JAMA. 255 (15): 2067–8. PMID 3959292.